TARGETING B CELLS AS ANTIGEN-PRESENTING CELLS FOR IMPROVED ANTI-PROSTATE CANCER DNA VACCINES

$2,292,988FY2017Department of the ArmyDOD

University Of Wisconsin System, Madison WI

Investigators